|
ZNF280D expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.855540E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.302390E-03 |
| Normal-vs-Stage2 |
6.801600E-01 |
| Normal-vs-Stage3 |
9.036200E-04 |
| Normal-vs-Stage4 |
3.791800E-01 |
| Stage1-vs-Stage2 |
1.459820E-01 |
| Stage1-vs-Stage3 |
4.249000E-01 |
| Stage1-vs-Stage4 |
7.385000E-01 |
| Stage2-vs-Stage3 |
1.134040E-01 |
| Stage2-vs-Stage4 |
6.087800E-01 |
| Stage3-vs-Stage4 |
5.381800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.761990E-03 |
| Normal-vs-AfricanAmerican |
3.299700E-02 |
| Normal-vs-Asian |
8.004100E-02 |
| Caucasian-vs-AfricanAmerican |
6.725000E-01 |
| Caucasian-vs-Asian |
8.795800E-01 |
| AfricanAmerican-vs-Asian |
7.772200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.555400E-04 |
| Normal-vs-Female |
1.085370E-01 |
| Male-vs-Female |
1.197400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.795160E-01 |
| Normal-vs-Extreme_Weight |
1.758480E-03 |
| Normal-vs-Obese |
6.523500E-03 |
| Normal-vs-Extreme_Obese |
2.716500E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.321200E-01 |
| Normal_Weight-vs-Obese |
3.580600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.506000E-01 |
| Extreme_Weight-vs-Obese |
7.872800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.708800E-01 |
| Obese-vs-Extreme_Obese |
7.616800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.807550E-02 |
| Normal-vs-Age(41-60Yrs) |
9.132000E-02 |
| Normal-vs-Age(61-80Yrs) |
3.376100E-04 |
| Normal-vs-Age(81-100Yrs) |
1.918430E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.362400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.586400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.707800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.790100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.269630E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.886600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.303590E-02 |
| Normal-VS-Type2 PRCC |
3.185000E-04 |
| Normal-VS-KIRP CIMP |
2.11639999999624E-05 |
| Normal-VS-Unclassified PRCC |
8.926400E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.235800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.438150E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.521400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.301050E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.325900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.772380E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.013200E-04 |
| Normal-vs-N1 |
1.695380E-01 |
| Normal-vs-N2 |
2.356700E-03 |
| N0-vs-N1 |
2.680600E-01 |
| N0-vs-N2 |
2.280400E-01 |
| N1-vs-N2 |
6.482100E-03 |
|
|
